News Search Results

Displaying Results 1376-1400 of 9211 "San Francisco"

Feb 24, 2026, 08:41 ET CoreWeave, Inc. (CRWV) Facing Securities Class Action Over Alleged Data Center Delays and Concealed Infrastructure Risks - Hagens Berman

CRWV Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is alerting investors in CoreWeave, Inc.

More news about: Hagens Berman Sobol Shapiro LLP


Feb 24, 2026, 08:40 ET BRBR SHAREHOLDER NOTICE: BellRing Brands (BRBR) Facing Securities Class Action Over Alleged Artificial Growth and $2.9 Billion Value Wipeout - Hagens Berman

SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in BellRing Brands, Inc. (NYSE: BRBR) regarding the March 23, 2026,

More news about: Hagens Berman Sobol Shapiro LLP


Feb 24, 2026, 08:38 ET RR SHAREHOLDER NOTICE: Richtech Robotics (RR) Facing Securities Class Action Amid Questions About Possible Pump and Dump - Hagens Berman

SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Richtech Robotics (NASDAQ: RR) has been hit with a securities class action lawsuit after Hunterbrook Media reported on January 29, 2026 that Microsoft denied a commercial

More news about: Hagens Berman Sobol Shapiro LLP


Feb 24, 2026, 08:36 ET Kyndryl Holdings (KD) Files Amended Quarterly and Fiscal Year Reports Detailing Material Internal Control Weaknesses After 3 Key Executives Depart, Securities Class Action Pending- Hagens Berman

SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Kyndryl Holdings, Inc. (NYSE: KD) filed two amended quarterly reports and one amended annual report providing further detail about problems previously reported on February

More news about: Hagens Berman Sobol Shapiro LLP


Feb 24, 2026, 08:34 ET Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Ignored Repeated FDA Warnings Against Filing Relacorilant NDA; Stock Plunged 50% on Revealed "Evidence Gaps"SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors

More news about: Hagens Berman Sobol Shapiro LLP


Feb 24, 2026, 08:30 ET Alexandria Real Estate Equities, Inc. to Hold Its First Quarter 2026 Operating and Financial Results Conference Call and Webcast on April 28, 2026

and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City. For more information, please visit 

More news about: Alexandria Real Estate Equities, Inc.


Feb 24, 2026, 08:30 ET Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership

Collaboration with Dr. Parhiz's lab at the University of Pennsylvania to advance mRNA delivery technologiesSAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Therna Biosciences, a biotechnology company pioneering programmable RNA medicines,

More news about: Therna Biosciences


Feb 24, 2026, 08:30 ET The Walt Disney Studios and World War II Exhibition Opens March 2026 at Dallas Holocaust and Human Rights Museum

as well as training and public-service films. The Walt Disney Studios and World War II is organized by The Walt Disney Family Museum, in San Francisco, California.

More news about: Dallas Holocaust and Human Rights Museum


Feb 24, 2026, 08:05 ET Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its fourth quarter and full year 2025 financial results after market close on Tuesday,

More news about: Rigel Pharmaceuticals, Inc.


Feb 24, 2026, 08:00 ET K36 Therapeutics Highlights First-in-Human KTX-2001 Prostate Cancer Study Design at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2026

of KTX-2001 will be presented in a Trial in Progress poster at the ASCO Genitourinary Cancers Symposium, taking place February 26–28, 2026, in San Francisco, California. KTX-2001 is a first-in-class, orally administered, selective NSD2 inhibitor being evaluated in patients with metastatic castration-resistant

More news about: K36 Therapeutics


Feb 24, 2026, 08:00 ET Producerflow Sets a New Standard for Distribution Infrastructure

solutions simplify and streamline producer onboarding and compliance for Carriers, MGAs, and AgenciesSAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Producerflow, an insurance software company, is building on its first year

More news about: Producerflow


Feb 24, 2026, 08:00 ET Stable Sea and dLocal join forces to power low-cost, B2B cross-border stablecoin payments

SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Stable

More news about: Stable Sea


Feb 24, 2026, 07:15 ET Mill Creek Announces Retail Additions at Modera Coral Springs

offices across the United States. Mill Creek is building its portfolio in many of the nation's most desirable markets in Seattle, Portland, the San Francisco Bay area, Sacramento, Southern California, Salt Lake City, Phoenix, Denver, Dallas, Austin, Houston, South Florida, Tampa, Orlando, Atlanta, Nashville,

More news about: Mill Creek Residential


Feb 24, 2026, 07:07 ET Hamilton Zanze Sponsors the Acquisition of Fairways on Green Valley

Garden-Style Apartment Community Features 320 Homes in Henderson, Nev.SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- 

More news about: Hamilton Zanze & Company


Feb 24, 2026, 06:30 ET Xenia Hotels & Resorts Reports Fourth Quarter and Full Year 2025 Results

Select upgrades to guest rooms at several properties including Renaissance Atlanta Waverly Hotel & Convention Center, Marriott San Francisco Airport Waterfront, Hyatt Centric Key West Resort & Spa, Hyatt Regency Santa Clara, Grand Bohemian Hotel Mountain Brook, Grand Bohemian Hotel

More news about: Xenia Hotels & Resorts, Inc.


Feb 24, 2026, 06:00 ET OpenTable Launches New Media Network, Connecting Brands with Millions of Global Diners

Media provides custom advertising and brand partnership solutions on the platform for the first timeSAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ --

More news about: OpenTable, Inc.


Feb 23, 2026, 17:50 ET Bay Area Transit Agency Leaders OK Standardized Sign Designs

New unified transit design guides are a first for the Bay AreaSAN FRANCISCO, Feb. 23, 2026 /PRNewswire/ -- The Regional Network Management (RNM) Council today approved the first set of transit wayfinding

More news about: Metropolitan Transportation Commission


Feb 23, 2026, 17:30 ET Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium

for presentation at the 2026 ASCO® Genitourinary (GU) Cancers Symposium (ASCO GU). The meeting is being held February 26-28, 2026, in San Francisco, California.Details of the poster presentations are below:Title: "ctDNA monitoring of FGFR3-altered metastatic urothelial cancer

More news about: Tyra Biosciences


Feb 23, 2026, 17:02 ET Microplastics Discovered in Prostate Tumors

part of a presentation during the American Society of Clinical Oncology's Genitourinary Cancers Symposium on Thursday, Feb. 26, at 11:30 a.m. in San Francisco. Titled Microplastics and Prostate Cancer (abstract number 79, poster board M7), the presentation is part of Poster Session A — Prostate

More news about: NYU Grossman School of Medicine and NYU Langone Health


Feb 23, 2026, 17:00 ET Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

- Vir Biotechnology to host conference call today at 2:30 p.m. PT / 5:30 p.m. ET -TOKYO and SAN FRANCISCO, Feb. 23, 2026 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas")

More news about: Astellas Pharma Inc.


Feb 23, 2026, 16:30 ET SiriusXM to Present at the 2026 Morgan Stanley Technology, Media & Telecom Conference

Witz, Chief Executive Officer will present on March 3, 2025, at 8:30 a.m. PT at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, CA. A webcast of the presentation will be available in the Investor Relations section of the SiriusXM website at 

More news about: Sirius XM Holdings Inc.


Feb 23, 2026, 16:06 ET AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE

Portfolio %1) San Francisco Intl Airport Series 2026-2 5.50%, 05/01/55

More news about: AllianceBernstein National Municipal Income Fund, Inc.


Feb 23, 2026, 16:05 ET Teradata to Present at Upcoming Investor Conferences

Citizen's 2026 Technology Conference in San Francisco, CA on March 2nd at 12:00 p.m. PTPresenter: John Ederer, Chief Financial OfficerMorgan Stanley's 2026 TMT Conference(1) in San Francisco, CA on March 3rd at 12:20 p.m. PTPresenters:

More news about: Teradata Corporation


Feb 23, 2026, 15:00 ET Women's Health Company Mira Calls for Federal Reform of U.S. Sex Education

SAN FRANCISCO, Feb. 23, 2026 /PRNewswire/ --

More news about: Quanovate Tech Inc, dba Mira


Feb 23, 2026, 13:00 ET Boston Joins World Economic Forum's Yes/Cities Initiative, Launching Innovation Challenge on Food, Health, and Resilience

Today, Yes/Boston officially launched as part of the World Economic Forum's global Yes/Cities initiative, becoming the third flagship city alongside San Francisco, USA and Bengaluru, India. Under the leadership of the World Economic Forum, in collaboration with Amazon Web Services, Citi, and Deloitte* – and

More news about: MassChallenge


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.